VEGFA and thyroid cancer: When treated with estrogen, the thyroid cancer cells displayed an enhanced VEGF secretion with 9455 pg/ml in B-CPAP and 1681 pg/ml in ML-1, which corresponds to a significant increase (50-55%) in VEGF secretion upon estrogen treatment.